By Denny Jacob
Elanco Animal Health will commercialize an avian flu vaccine for dairy cattle after reaching an agreement with Medgene.
The developer and manufacturer of pet and farm-animal products said on Tuesday that Medgene reported that its vaccine has met all requirements of the U.S. Agriculture Department's platform technology guidelines and is in the final stages of review for conditional license approval.
Elanco said a cattle vaccine will be critical to slow transmission between birds and cattle, a potential catalyst as a bird flu outbreak has roiled farms and sent egg prices soaring.
"As egg prices soar and milk production wanes in infected dairies, the need for new solutions to curb disease spread is evident," said Elanco Chief Executive Jeff Simmons.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
February 25, 2025 07:39 ET (12:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.